Solid form (polymorph, solvate, salt, and co-crystal) screening is vital for successful development of a drug formulation. Each solid form has characteristic properties; and performing a screening allows selection of the most prospective solid forms with best properties. Moreover, regulatory agencies require that a company demonstrates reasonable efforts to identify the polymorphs of a drug substance and eliminates the possibility of polymorph conversions.
